Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
28%
OVERLAP
BY WEIGHT
32
# OF OVERLAPPING
HOLDINGS
IBB
260
HOLDINGS
15%
ALSO IN HELX
HELX
67
HOLDINGS
58%
ALSO IN IBB
SECTOR DRIFT (IBB minus HELX)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IBB |
Weight in HELX |
Overlap | |
|---|---|---|---|---|
 |
ALNYLAM PHARMACEUTICALS INC | 4.5% | 3.6% | 3.6% |
|
INSMED INC | 3.2% | 4.3% | 3.2% |
|
VERTEX PHARMACEUTICALS INC | 8.7% | 2.7% | 2.7% |
|
NATERA INC | 2.7% | 6.9% | 2.7% |
|
REGENERON PHARMACEUTICALS | 7.0% | 2.3% | 2.3% |
IBB Overweight Relative to HELX
|
GILEAD SCIENCES INC | 7.8% |
|
AMGEN INC | 7.6% |
|
VERTEX PHARMACEUTICALS INC | 5.9% |
|
REGENERON PHARMACEUTICALS | 4.6% |
 |
ARGENX SE ADR | 2.8% |
|
BIOGEN IDEC INC | 2.4% |
|
BEIGENE LTD. SPONSORED ADR | 1.8% |
|
ILLUMINA INC | 1.8% |
|
INCYTE CORP | 1.8% |
|
REVOLUTION MEDICINES, INC. | 1.7% |
IBB Underweight Relative to HELX
|
GUARDANT HEALTH, INC. | -6.8% |
|
NATERA INC | -4.2% |
|
KRYSTAL BIOTECH, INC. | -4.0% |
|
MEDPACE HOLDINGS, INC. | -3.2% |
|
ADAPTIVE BIOTECHNOLOGIES CORP. | -3.1% |
|
LIGAND PHARMACEUTICALS-CL B | -3.0% |
|
BRIDGEBIO PHARMA, INC. | -2.8% |
 |
ASTRAZENECA PLC-SPONS ADR | -2.8% |
|
ELI LILLY & CO | -2.7% |
|
GENEDX HOLDINGS CORP. CLASS A | -2.3% |